ATE541858T1 - Präparation von intravenösem immunglobulin mit ultrahoher ausbeute - Google Patents

Präparation von intravenösem immunglobulin mit ultrahoher ausbeute

Info

Publication number
ATE541858T1
ATE541858T1 AT06800767T AT06800767T ATE541858T1 AT E541858 T1 ATE541858 T1 AT E541858T1 AT 06800767 T AT06800767 T AT 06800767T AT 06800767 T AT06800767 T AT 06800767T AT E541858 T1 ATE541858 T1 AT E541858T1
Authority
AT
Austria
Prior art keywords
preparation
high yield
ultra high
intravenous immunoglobulin
sodium citrate
Prior art date
Application number
AT06800767T
Other languages
English (en)
Inventor
Gene Zurlo
Dennis Curtin
Allan Louderback
Original Assignee
Plasma Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasma Technologies Llc filed Critical Plasma Technologies Llc
Priority claimed from PCT/US2006/030465 external-priority patent/WO2007030244A2/en
Application granted granted Critical
Publication of ATE541858T1 publication Critical patent/ATE541858T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06800767T 2005-09-01 2006-08-04 Präparation von intravenösem immunglobulin mit ultrahoher ausbeute ATE541858T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/217,956 US20070049732A1 (en) 2005-09-01 2005-09-01 Ultra-high yield intravenous immune globulin preparation
US11/232,527 US7879331B2 (en) 2005-09-01 2005-09-22 Ultra-high yield intravenous immune globulin preparation
PCT/US2006/030465 WO2007030244A2 (en) 2005-09-01 2006-08-04 An ultra-high yield intravenous immune globulin preparation

Publications (1)

Publication Number Publication Date
ATE541858T1 true ATE541858T1 (de) 2012-02-15

Family

ID=37805216

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06800767T ATE541858T1 (de) 2005-09-01 2006-08-04 Präparation von intravenösem immunglobulin mit ultrahoher ausbeute

Country Status (6)

Country Link
US (3) US20070049732A1 (de)
JP (1) JP5178518B2 (de)
CN (1) CN101528776B (de)
AT (1) ATE541858T1 (de)
CA (1) CA2621025C (de)
ES (1) ES2384930T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA012801B1 (ru) 2005-06-14 2009-12-30 Эмджен Инк. Самобуферирующиеся композиции белков
EP2271382B1 (de) * 2008-04-15 2013-03-13 Grifols Therapeutics Inc. Zweistufige Ultrafiltrierung/Diafiltrierung
US20100322943A1 (en) 2009-06-17 2010-12-23 Thomas Cantor Therapeutic and diagnostic affinity purified specific polyclonal antibodies
IT1397061B1 (it) 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
AU2012284122B2 (en) 2011-07-18 2017-06-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for inhibiting polyomavirus-associated pathology
WO2013066986A1 (en) * 2011-10-31 2013-05-10 Puget Sound Blood Genter Antibody response phenotyping
CN102949719A (zh) * 2012-04-28 2013-03-06 上海市徐汇区中心医院 静脉注射免疫球蛋白抑制霍乱毒素和半乳糖凝集素-1结合到神经节苷脂gm1
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
US9556253B2 (en) 2014-12-02 2017-01-31 Hemarus Therapeutics Limited Process for increased yield of immunoglobulin from human plasma
CN115925781A (zh) * 2015-10-15 2023-04-07 普莱泽玛科技有限公司 从血浆中提取蛋白质的方法
WO2017136785A1 (en) 2016-02-03 2017-08-10 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
EP3528787A4 (de) 2016-10-21 2020-05-06 Amgen Inc. Pharmazeutische formulierungen und verfahren zur herstellung davon
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
CN108008060B (zh) * 2017-09-21 2020-07-28 中国农业科学院农业质量标准与检测技术研究所 一种饲料中羟脯氨酸的测定方法及试剂
CA3149777A1 (en) * 2019-09-20 2021-03-25 Eugene ZURLO Therapeutic protein compositions and methods
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation
EP4271706A1 (de) * 2020-12-28 2023-11-08 Plasma Technologies LLC Systeme und verfahren zur isolierung von immunglobulin g im prozessmassstab
CN115369104B (zh) * 2022-09-27 2023-09-08 四川新川义生物科技有限责任公司 一种精制胃蛋白酶的方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US4067863A (en) 1969-03-28 1978-01-10 Watt John G Blood plasma fractionation
CA1064396A (en) 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
JPS5234918A (en) 1975-09-06 1977-03-17 Biotest Serum Institut Gmbh Production of gmmaglobulin suitable for dosing into vein
US4126605A (en) 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
US4296027A (en) 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
US4136094A (en) 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
GB2040990B (en) * 1977-11-17 1982-10-06 Procter & Gamble Granular detergent compositions for improved greasy soil removal
US4163370A (en) 1977-11-21 1979-08-07 Corning Glass Works Controlling the drawing rollers to produce diameter perturbations in an optical waveguide
DE2835843A1 (de) 1978-08-16 1980-02-28 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
DE2837168A1 (de) 1978-08-25 1980-03-06 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung
DE2901822A1 (de) 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
US4246085A (en) 1979-02-16 1981-01-20 United Kingdom Atomic Energy Authority Fractionation of proteins
JPS5681521A (en) 1979-12-10 1981-07-03 Toyo Soda Mfg Co Ltd Separation of blood serum and protein
US4321192A (en) 1980-01-10 1982-03-23 Ionics Incorporated Fractionation of protein mixtures by salt addition followed by dialysis treatment
JPS5855432A (ja) 1981-09-29 1983-04-01 Fujirebio Inc 静脈注射用免疫グロブリンの製法
US4371520A (en) 1981-10-28 1983-02-01 The Green Cross Corporation Process for preparing immunoglobulin suitable for intravenous injection
US4624780A (en) 1982-06-28 1986-11-25 Alpha Therapeutic Corporation Fractionation of blood plasma
US4639513A (en) 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US4486282A (en) * 1983-02-22 1984-12-04 University Patents, Inc. Precipitation of proteins from salt-containing proteinaceous fluids employing a desalting treatment, and use thereof in selective plasmapheresis
JPS59157017A (ja) 1983-02-25 1984-09-06 Green Cross Corp:The 静脈投与用γ−グロブリン製剤
FR2543448A1 (fr) 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4835257A (en) 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
DE3640513A1 (de) 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
US5310877A (en) 1993-04-08 1994-05-10 E. I. Du Pont De Nemours And Company Method for separating serum albumin and gamma globulin
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US5561115A (en) 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
TW491855B (en) 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
GB9705810D0 (en) 1997-03-20 1997-05-07 Common Services Agency Intravenous immune globulin
AT407159B (de) * 1997-06-13 2001-01-25 Immuno Ag Verfahren zur abreicherung von viralen und molekularen pathogenen aus einem biologischen material
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
JP4685238B2 (ja) 1998-06-09 2011-05-18 ツエー・エス・エル・ベーリング・アクチエンゲゼルシヤフト 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
AUPP971399A0 (en) * 1999-04-12 1999-05-06 Life Therapeutics Limited Separation of plasma components
SE0001128D0 (sv) 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
BR0207058A (pt) * 2001-02-07 2004-02-17 Shanbrom Tech Llc Método para reduzir doença associada com transfusão e efeitos adversos no plasma para aumentar a pureza e segurança de múltiplos componentes derivados de sangue, crioprecipitado enriquecido, plasma crio-exaurido, e, cola de fibrina
US6806355B2 (en) 2001-08-14 2004-10-19 Statens Serum Institut Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
US6881573B2 (en) 2003-09-12 2005-04-19 Allan L. Louderback Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses

Also Published As

Publication number Publication date
JP5178518B2 (ja) 2013-04-10
JP2009507015A (ja) 2009-02-19
US20070049732A1 (en) 2007-03-01
US7879331B2 (en) 2011-02-01
CN101528776B (zh) 2014-01-08
US20070049733A1 (en) 2007-03-01
CA2621025A1 (en) 2007-03-15
ES2384930T3 (es) 2012-07-16
CA2621025C (en) 2014-10-14
CN101528776A (zh) 2009-09-09
US20080242844A1 (en) 2008-10-02

Similar Documents

Publication Publication Date Title
ATE541858T1 (de) Präparation von intravenösem immunglobulin mit ultrahoher ausbeute
WO2007030244A3 (en) An ultra-high yield intravenous immune globulin preparation
HRP20211794T1 (hr) Humana antitijela za pd-1
JP2020500538A5 (de)
AR097651A1 (es) Métodos y composiciones que comprenden polipéptidos recombinantes purificados
MX2018009331A (es) Metodos para extraer proteinas a partir de un material a base de sangre.
AU2018253630A1 (en) Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
AR086579A1 (es) Proteinas de union a antigeno
PE20142242A1 (es) Anticuerpos humanos anti-cd27, metodos, y usos
DK1536848T3 (da) Fremgangsmåde til fremstilling af et antimikrobielt plastprodukt
PE20140771A1 (es) Anticuerpos anti-ige apoptoticos
FI20010977A (fi) Kromatografinen erotusmenetelmä
PE20220392A1 (es) Moleculas de union a claudina-6 y usos de las mismas
RU2016111137A (ru) Сконструированные конъюгаты против dll3 и способы применения
NO20050090L (no) Fremgangsmate for fremstilling av et virus-inaktivert trombinpreparat
RS54883B1 (sr) Anti-cd79b antitela i imunokonjugati i metode upotrebe
CY1115456T1 (el) Μεθοδος χορηγησης αντισωματων αντι-ιl-5
RU2018125624A (ru) Антитела к с5 и способы их применения
AR050641A1 (es) Proceso para la concentracion de anticuerpos y productos terapeuticos de los mismos
NZ596603A (en) A collection of antibodies or fragments having properties relevant to developability
PE20191045A1 (es) Anticuerpos anti-il-33 y usos de los mismos
AR099625A1 (es) Anticuerpos de il-21
NZ628529A (en) Fraction i-iv-1 precipitation of immunoglobins from plasma
WO2019224713A3 (en) Monospecific and multispecific anti-tmeff2 antibodies and there uses
MY197735A (en) Pharmaceutical combinations comprising an anti-ly75 antibody